The p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression
Proceedings of the National Academy of Sciences, Volume 123, Issue 46, November 2026.
Proceedings of the National Academy of Sciences, Volume 123, Issue 46, November 2026.